121 related articles for article (PubMed ID: 22963770)
1. Regulation of human growth and differentiation factor 3 gene expression by NANOG in human embryonic carcinoma NCCIT cells.
Park SW; Lim HY; Do HJ; Sung B; Huh SH; Uhm SJ; Song H; Chung HJ; Kim JH; Kim NH; Kim JH
FEBS Lett; 2012 Sep; 586(19):3529-35. PubMed ID: 22963770
[TBL] [Abstract][Full Text] [Related]
2. Growth and Differentiation Factor 3 Is Transcriptionally Regulated by OCT4 in Human Embryonic Carcinoma Cells.
Han MH; Park SW; Do HJ; Chung HJ; Song H; Kim JH; Kim NH; Park KH; Kim JH
Biol Pharm Bull; 2016; 39(11):1802-1808. PubMed ID: 27803451
[TBL] [Abstract][Full Text] [Related]
3. Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells.
Chen T; He S; Zhang Z; Gao W; Yu L; Tan Y
Exp Cell Res; 2014 Aug; 326(2):326-35. PubMed ID: 24803390
[TBL] [Abstract][Full Text] [Related]
4. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression.
You JS; Kang JK; Seo DW; Park JH; Park JW; Lee JC; Jeon YJ; Cho EJ; Han JW
Cancer Res; 2009 Jul; 69(14):5716-25. PubMed ID: 19567677
[TBL] [Abstract][Full Text] [Related]
5. The expression of the embryonic gene Cripto-1 is regulated by OCT4 in human embryonal carcinoma NCCIT cells.
Park SW; Do HJ; Han MH; Choi W; Kim JH
FEBS Lett; 2018 Jan; 592(1):24-35. PubMed ID: 29223130
[TBL] [Abstract][Full Text] [Related]
6. Epithelium-specific ETS transcription factor-1 regulates NANOG expression and inhibits NANOG-induced proliferation of human embryonic carcinoma cells.
Park SW; Do HJ; Choi W; Lim DS; Park KH; Kim JH
Biochimie; 2021 Jul; 186():33-42. PubMed ID: 33865902
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of human Oct4 by steroidogenic factor-1.
Yang HM; Do HJ; Kim DK; Park JK; Chang WK; Chung HM; Choi SY; Kim JH
J Cell Biochem; 2007 Aug; 101(5):1198-209. PubMed ID: 17226773
[TBL] [Abstract][Full Text] [Related]
8. Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma.
Clark AT; Rodriguez RT; Bodnar MS; Abeyta MJ; Cedars MI; Turek PJ; Firpo MT; Reijo Pera RA
Stem Cells; 2004; 22(2):169-79. PubMed ID: 14990856
[TBL] [Abstract][Full Text] [Related]
9. The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus.
Pan G; Pei D
J Biol Chem; 2005 Jan; 280(2):1401-7. PubMed ID: 15502159
[TBL] [Abstract][Full Text] [Related]
10. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells.
Bahrami AR; Matin MM; Andrews PW
Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837
[TBL] [Abstract][Full Text] [Related]
11. NANOG gene expression is regulated by the ETS transcription factor ETV4 in human embryonic carcinoma NCCIT cells.
Park SW; Do HJ; Choi W; Song H; Chung HJ; Kim JH
Biochem Biophys Res Commun; 2017 Jun; 487(3):532-538. PubMed ID: 28412366
[TBL] [Abstract][Full Text] [Related]
12. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
[TBL] [Abstract][Full Text] [Related]
13. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human.
Hart AH; Hartley L; Ibrahim M; Robb L
Dev Dyn; 2004 May; 230(1):187-98. PubMed ID: 15108323
[TBL] [Abstract][Full Text] [Related]
14. Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog.
Pan GJ; Pei DQ
Cell Res; 2003 Dec; 13(6):499-502. PubMed ID: 14728807
[TBL] [Abstract][Full Text] [Related]
15. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
[TBL] [Abstract][Full Text] [Related]
16. Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation.
Wang X; Wang J; Huang V; Place RF; Li LC
Biochem J; 2012 May; 443(3):821-8. PubMed ID: 22339500
[TBL] [Abstract][Full Text] [Related]
17. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 630 Represses NANOG Expression through Transcriptional and Post-Transcriptional Regulation in Human Embryonal Carcinoma Cells.
Chu WK; Hung LM; Hou CW; Chen JK
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008480
[TBL] [Abstract][Full Text] [Related]
19. Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes.
Boer B; Kopp J; Mallanna S; Desler M; Chakravarthy H; Wilder PJ; Bernadt C; Rizzino A
Nucleic Acids Res; 2007; 35(6):1773-86. PubMed ID: 17324942
[TBL] [Abstract][Full Text] [Related]
20. Regulation of OCT4 gene expression by liver receptor homolog-1 in human embryonic carcinoma cells.
Sung B; Do HJ; Park SW; Huh SH; Oh JH; Chung HJ; Kang MJ; Kim JH; Kim NH; Kim JH
Biochem Biophys Res Commun; 2012 Oct; 427(2):315-20. PubMed ID: 23000165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
